0001650664-23-000019.txt : 20231109 0001650664-23-000019.hdr.sgml : 20231109 20231109163126 ACCESSION NUMBER: 0001650664-23-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231107 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eaton Bruce CENTRAL INDEX KEY: 0001874831 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 231393116 MAIL ADDRESS: STREET 1: C/O EDITAS MEDICINE, INC. STREET 2: 1 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 wk-form4_1699565469.xml FORM 4 X0508 4 2023-11-07 0 0001650664 Editas Medicine, Inc. EDIT 0001874831 Eaton Bruce C/O EDITAS MEDICINE, INC. 11 HURLEY ST. CAMBRIDGE MA 02141 0 1 0 0 EVP, CBO AND CTO 1 Common Stock 2023-11-07 4 S 0 139 8.40 D 75589 D Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2023. The sale does not represent a discretionary trade by the Reporting Person. /s/ Bruce Eaton 2023-11-09